started · updated
vVardis targets $4.37 billion valuation in US IPO
Swiss dental startup vVardis is planning an initial public offering on the New York Stock Exchange, seeking a valuation of up to $4.37 billion. The Zug-based company intends to offer 9.5 million shares priced between $21 and $24 each, aiming to raise approximately $228.6 million.
Founded in 2020 by entrepreneurs Haley and Goly Abivardi, vVardis specializes in treatments for early-stage tooth decay that do not require drilling or anesthesia. The company develops products under the Curodont brand, which aim to support the natural repair of tooth enamel. The firm has seen significant growth in the US market, reporting a 112 percent increase in revenue for its Curodont Repair Fluoride Plus product during the first nine months of 2026.
Entities
Goly Abivardi · Haley Abivardi · New York Stock Exchange · Zug · vVardis